Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by XIAO-MIN ZHANG
Synergistic Effect of HMGB1 Knockdown and Cordycepin in the K562 Human Chronic Myeloid Leukemia Cell Line
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Related publications
Reversal Effect of Arsenic Sensitivity in Human Leukemia Cell Line K562 and K562/Adm Using Realgar Transforming Solution
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Single-Nucleotide Polymorphisms of ABCG2 Increase the Efficacy of Tyrosine Kinase Inhibitors in the K562 Chronic Myeloid Leukemia Cell Line
Pharmacogenetics and Genomics
Molecular Medicine
Genetics
Molecular Biology
Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method
Balkan Medical Journal
Medicine
ITR‑284 Modulates Cell Differentiation in Human Chronic Myelogenous Leukemia K562 Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Effects of Epigallocatechin-3-Gallate (EGCG) on Cell Cycle Distribution and DNA Integrity of K562 Cells, a Human Chronic Myeloid Leukemia
Jurnal Sains Kesihatan Malaysia
Global Proteome Quantification for Discovering Imatinib-Induced Perturbation of Multiple Biological Pathways in K562 Human Chronic Myeloid Leukemia Cells
Journal of Proteome Research
Biochemistry
Chemistry
A Stronger Reversal Effect of the Combination of Dasatinib and Menadione on P-Gp-Mediated Multidrug Resistance in Human Leukemia K562/Adr Cell Line
RSC Advances
Chemistry
Chemical Engineering
TRIB2 Knockdown as a Regulator of Chemotherapy Resistance and Proliferation via the ERK/STAT3 Signaling Pathway in Human Chronic Myelogenous Leukemia K562/Adm Cells
Oncology Reports
Medicine
Cancer Research
Oncology
Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia
Cancer
Cancer Research
Oncology
